Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,007
Total Claims
$975K
Drug Cost
645
Beneficiaries
$1,512
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-92%
Opioid rate vs peers
0.2% vs 2.2% avg
+7%
Cost per patient vs peers
$1,512 vs $1,411 avg
+87%
Brand preference vs peers
19.8% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
22
Opioid Claims
$312
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,371 claims · $750K
Generic: 9,576 claims · $222K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 378 | $109K |
| Paliperidone Palmitate | 14 | $49K |
| Rivaroxaban | 132 | $35K |
| Varicella-Zoster Ge/As01b/Pf | 149 | $31K |
| Mirabegron | 134 | $30K |
| Rsv Vacc, Pref A And Pref B/Pf | 79 | $26K |
| Liraglutide | 26 | $22K |
| Cariprazine Hcl | 32 | $21K |
| Semaglutide | 20 | $20K |
| Sitagliptin Phosphate | 68 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 56 | $18K |
| Empagliflozin | 58 | $16K |
| Dulaglutide | 23 | $16K |
| Dextromethorphan Hbr/Quinidine | 21 | $15K |
| Lipase/Protease/Amylase | 12 | $14K |
Prescribing Profile
Patient Profile
76
Avg Age
56%
Female
1.96
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About